Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)
2.420
-0.020 (-0.82%)
Apr 24, 2026, 3:51 PM HKT
HKG:8049 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 143.1 | 235.85 | 352.14 | 113.6 | 55.29 |
Short-Term Investments | 470.98 | 254.48 | 215.32 | 673.13 | 68.43 |
Trading Asset Securities | 74.24 | 93.27 | 90.61 | 263.07 | 176.53 |
Cash & Short-Term Investments | 688.32 | 583.59 | 658.06 | 1,050 | 300.26 |
Cash Growth | 17.95% | -11.32% | -37.32% | 249.63% | 5.89% |
Accounts Receivable | 428.36 | 412.91 | 395.36 | 451.02 | 399.61 |
Other Receivables | 14.89 | 5.33 | 8.71 | 116.52 | 96.67 |
Receivables | 443.26 | 418.23 | 404.06 | 567.54 | 496.28 |
Inventory | 75.6 | 59.97 | 102.97 | 132.99 | 86.31 |
Other Current Assets | 15.65 | 37.25 | 36.05 | 17.15 | 7.02 |
Total Current Assets | 1,223 | 1,099 | 1,201 | 1,767 | 889.87 |
Property, Plant & Equipment | 297.48 | 313.07 | 329.55 | 360.28 | 398.15 |
Long-Term Investments | 1,085 | 1,049 | 724.16 | 211.41 | 776.49 |
Goodwill | 6.25 | 6.25 | 6.25 | 6.25 | 6.25 |
Other Intangible Assets | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 |
Long-Term Deferred Tax Assets | 34.14 | 34.32 | 28.51 | 27.4 | 1.51 |
Other Long-Term Assets | 25.62 | 29.66 | 29.2 | - | - |
Total Assets | 2,671 | 2,531 | 2,319 | 2,373 | 2,072 |
Accounts Payable | 61.95 | 63.54 | 70.58 | 65.69 | 51.34 |
Accrued Expenses | 456.29 | 366.62 | 299.85 | 295.28 | 33.78 |
Current Portion of Long-Term Debt | 0.4 | 72.4 | 8.4 | 0.4 | 0.4 |
Current Income Taxes Payable | 24.76 | 3.61 | 16.68 | 25.66 | 32.45 |
Current Unearned Revenue | 29.16 | 22.63 | 16.32 | 24.94 | 16.81 |
Other Current Liabilities | 370.33 | 331.87 | 313.45 | 302.63 | 437.03 |
Total Current Liabilities | 942.89 | 860.67 | 725.29 | 714.59 | 571.79 |
Long-Term Debt | - | - | 72 | - | - |
Long-Term Unearned Revenue | 33.57 | 34.95 | 35.54 | 40.97 | 41.95 |
Long-Term Deferred Tax Liabilities | 1.22 | 1.94 | 2.74 | 3.02 | 3.86 |
Other Long-Term Liabilities | 5.07 | 3.93 | 2.87 | 1.96 | 0.95 |
Total Liabilities | 982.74 | 901.49 | 838.44 | 760.54 | 618.56 |
Common Stock | 56.03 | 56.03 | 56.03 | 56.03 | 56.03 |
Additional Paid-In Capital | 51.1 | 51.1 | 51.1 | 51.1 | 51.1 |
Retained Earnings | 1,581 | 1,522 | 1,373 | 1,505 | 1,347 |
Shareholders' Equity | 1,688 | 1,630 | 1,480 | 1,612 | 1,454 |
Total Liabilities & Equity | 2,671 | 2,531 | 2,319 | 2,373 | 2,072 |
Total Debt | 0.4 | 72.4 | 80.4 | 0.4 | 0.4 |
Net Cash (Debt) | 687.92 | 511.19 | 577.66 | 1,049 | 299.86 |
Net Cash Growth | 34.57% | -11.51% | -44.95% | 249.97% | 5.90% |
Net Cash Per Share | 1.23 | 0.91 | 1.03 | 1.87 | 0.54 |
Filing Date Shares Outstanding | 560.25 | 560.25 | 560.25 | 560.25 | 560.25 |
Total Common Shares Outstanding | 560.25 | 560.25 | 560.25 | 560.25 | 560.25 |
Working Capital | 279.93 | 238.38 | 475.85 | 1,053 | 318.08 |
Book Value Per Share | 3.01 | 2.91 | 2.64 | 2.88 | 2.59 |
Tangible Book Value | 1,682 | 1,623 | 1,474 | 1,606 | 1,447 |
Tangible Book Value Per Share | 3.00 | 2.90 | 2.63 | 2.87 | 2.58 |
Buildings | 238.47 | 238.26 | 238.18 | 259.99 | 189.32 |
Machinery | 283.93 | 273.77 | 262.91 | 252 | 193.29 |
Construction In Progress | - | - | 4.9 | - | 147.86 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.